National plaintiffs' law firm Berger Montague PCannounces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) (“LifeMD” or the “Company”) on behalf of investors who purchased or acquired shares during the period fromMay 7, 2025 through August 5, 2025 (the “Class Period”).
https://mma.prnewswire.com/media/232479/berger_montague.jpg
Investor Deadline: Investors who purchased or acquired LifeMD securities during the Class Period may, no later than October 27, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your rights, CLICK HERE.
LifeMD is a direct-to-consumer telehealth company headquartered in New York, New York. The Company provides virtual healthcare services and pharmacy offerings across areas including men's health, obesity treatment, and chronic care.
The complaint alleges the Company materially overstated its competitive position and was reckless in raising its 2025 guidance, failing to properly account for rising customer acquisition costs in both its RexMD segment and its obesity drug offerings, including Wegovy and Zepbound.
When the truth about the Company's finances were revealed, LifeMD shares lost 44% of their value in a single trading session.
If you are a LifeMDinvestor and would like to learn more about this action, CLICK HEREor please contact Berger Montague: Andrew Abramowitz at aabramowitz@bergermontague.com or (215) 875-3015, or Caitlin Adorni at cadorni@bergermontague.com or (267)764-4865.
About Berger MontagueBerger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco, Chicago, Malvern, PA, and Toronto has been a pioneer in securities class action litigationsince its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.
For more information or to discuss your rights, please contact:Andrew AbramowitzSenior CounselBerger Montague(215) 875-3015aabramowitz@bergermontague.com
Caitlin AdorniDirector of Portfolio and Institutional Client Monitoring ServicesBerger Montague(267) 764-4865cadorni@bergermontague.com
https://c212.net/c/img/favicon.png?sn=DC61634&sd=2025-08-28
View original content to download multimedia:https://www.prnewswire.com/news-releases/berger-montague-pc-investigating-claims-on-behalf-of-lifemd-inc-nasdaq-lfmd-investors-after-class-action-filing-302541538.html
SOURCE Berger Montague
https://rt.newswire.ca/rt.gif?NewsItemId=DC61634&Transmission_Id=202508281851PR_NEWS_USPR_____DC61634&DateId=20250828